Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin?
Saved in:
| Title: | Should patients with non-muscle-invasive bladder cancer discontinue fibrin clot inhibitors during bacille Calmette-Guérin? |
|---|---|
| Authors: | Lobo N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hensley PJ; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bree KK; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nogueras-Gonzalez GM; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Navai N; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dinney CP; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| Source: | BJU international [BJU Int] 2022 Oct; Vol. 130 (4), pp. 463-469. Date of Electronic Publication: 2021 Dec 13. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
